INTRODUCTION
Intracellular formation, metabolism, and release of Homocysteine into the extracellular compartment determine the concentration of homocysteine in extracellular media (e.g., plasma/serum), which in turn is the basis for measuring plasma/serum homocysteine as an extracellular marker for human diseases. Elevated levels of serum homocysteine have been associated with state of coronary heart diseases. High levels of homocysteine in the serum, above15 µmol/L, a medical condition called hyper homocysteinemia. In patients with type 2 diabetes mellitus, who is known to have a 2 to 4 fold increased risk for coronary heart disease (CHD) 1 . Homocystinuria refers to a group of rare inborn 200 DOI: 10.5958/j.2319-5886.2.2. 036 errors of metabolism resulting in high levels of circulating homocysteine 100 µmol/L and urinary homocysteine.
2 Several epidemiological studies have been shown a relation between total homocysteine levels and coronary heart diseases [3] [4] [5] [6] [7] . In previous studies with diabetic patients, the association between elevated plasma homocysteine level and CHD events has been strong in case control and cross sectional studies 8 -12 
Statistical analysis:
All results were shown as mean±SD. The results were evaluated using Student's t-test. P-value <0.05 was considered statistically significant. Statistical analysis was performed using SPSS software
RESULTS
In normal individuals (control group) glucose mean level was 96.44 ± 11mg/dl. In Type 2 diabetic patients the glucose was significantly raised being 244.4 ± 41.08 mg/dl. Serum total Cholesterol was 175.92 ± 22.84mg /dl. In Type 2 diabetic patients the mean levels of serum total cholesterol was significantly raised, the value being 201.2 ± 29.69mg / dl. The Triglycerides in the control group are 105.2 ± 27.82 mg/dl, while inType2 diabetic patients the mean triglycerides levels have significantly raised to 151.32 ± 36.73 mg/dl. The mean HDL-Cholesterol in normal is 41.96 ± 2.58mg/dl, while the mean value of HDL-Cholesterol in Type 2 diabetic patients is 40.08±3.29mg/dl. HDL Cholesterol slightly decreased in Type 2 diabetic patients. The LDLCholesterol mean level in normal individuals was 109.16 ± 25.54 mg/dl. In Type 2 diabetic patients the LDL-Cholesterol was significantly raised being 128.08 ± 29.09 mg/dl. The homocysteine in the control group is 8.924 ± 2.96 µmol/l, while in Type 2 diabetic patients the mean homocysteine levels have significantly raised to 15.064 ± 4.82 µmol/l. There is a significant difference of glucose, Cholesterol, triglycerides, HDL, LDL, homocysteine in control group & Type 2 diabetic group. 
CONCLUSION
In summary, our study shows that serum homocysteine levels are significantly raised; it is an independent risk factor for future CHD events in patients with type 2 diabetes with or without known CHD. 
